Arcutis Biotherapeutics (ARQT) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q4 2024 value amounting to $2.6 million.
- Arcutis Biotherapeutics' Accumulated Depreciation & Amortization rose 3326.4% to $2.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.6 million, marking a year-over-year increase of 3326.4%. This contributed to the annual value of $2.6 million for FY2024, which is 3326.4% up from last year.
- As of Q4 2024, Arcutis Biotherapeutics' Accumulated Depreciation & Amortization stood at $2.6 million, which was up 3326.4% from $1.9 million recorded in Q4 2023.
- Over the past 5 years, Arcutis Biotherapeutics' Accumulated Depreciation & Amortization peaked at $2.6 million during Q4 2024, and registered a low of $78000.0 during Q4 2020.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $914500.0 (2022), whereas its average is $1.0 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 58205.13% in 2021, then skyrocketed by 3326.4% in 2024.
- Over the past 5 years, Arcutis Biotherapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $78000.0 in 2020, then surged by 582.05% to $532000.0 in 2021, then soared by 116.73% to $1.2 million in 2022, then skyrocketed by 66.87% to $1.9 million in 2023, then skyrocketed by 33.26% to $2.6 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $2.6 million for Q4 2024, versus $1.9 million for Q4 2023 and $1.7 million for Q3 2023.